Literature DB >> 30314948

HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression.

Li Zhang1, Qinghua Wu2, Changyu He3, Dongyu Liang4, Qingqing Yi4, Junfeng Shi5, Boshun Wan1, Rong Yang6, Luyi Li4, Shuang Sha7, Qing Chang8.   

Abstract

BACKGROUND: HOXB9 is a homeobox transcription factor which plays an important role in carcinoma development. This protein has been shown to inhibit cancer cell proliferation. However, the mechanisms that underpin HOXB9-mediated inhibition of cellular proliferation remain to be elucidated.
METHODS: In this study, two gastric cancer cell lines, SGC7901 and MKN45, were transfected with plasmids pLVX-HOXB9 and shHOXB9. These transfections resulted in the over-expression of the HOXB9 gene in the SGC7901/HOXB9 cells and knockdown of the HOXB9 gene in the MKN45/shHOXB9 cells.
RESULTS: Over-expression of the HOXB9 gene in the SGC7901/HOXB9 cells caused an increase in the apoptotic rate and a concomitant reduction in metastatic ability compared with the knocked-down MKN45/shHOXB9 cells. Moreover, a reduction in the expression of the phosphorylated-Akt protein was observed in the SGC7901/HOXB9 cells, while an increase in expression of the same protein was observed in the MKN45/shHOXB9 cells. We also observed that HOXB9 mediated a reduction in both NF-κB and N-cadherin and Snail protein expression. Conversely, HOXB9 caused an increase in the expression of E-cadherin.
CONCLUSIONS: In summary, this study reports that HOXB9 can suppress both phosphorylated-Akt expression and NF-κB activity. The latter phenomenon affects Snail protein expression and the inhibition of gastric carcinoma proliferation.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  E-cadherin; MKN45 cells; N-cadherin; SGC7901 cells

Mesh:

Substances:

Year:  2018        PMID: 30314948     DOI: 10.1016/j.dld.2018.08.018

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

1.  A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.

Authors:  Xiao Yang; Yuan Cheng; Xingchen Li; Jingyi Zhou; Yangyang Dong; Boqiang Shen; Lijun Zhao; Jianliu Wang
Journal:  Onco Targets Ther       Date:  2021-04-13       Impact factor: 4.147

2.  Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses.

Authors:  Sheng-Fang Su; Chia-Hsin Liu; Chiou-Ling Cheng; Chao-Chi Ho; Tsung-Ying Yang; Kun-Chieh Chen; Kuo-Hsuan Hsu; Jeng-Sen Tseng; Huei-Wen Chen; Gee-Chen Chang; Sung-Liang Yu; Ker-Chau Li
Journal:  JCO Precis Oncol       Date:  2021-02-19

3.  Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.

Authors:  Xiao Jin; Lu Dai; Yilan Ma; Jiayan Wang; Haihao Yan; Ye Jin; Xiaojuan Zhu; Zheng Liu
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

4.  HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.

Authors:  HongShan Zheng; ChenLong Li; ZhenZhe Li; KaiBin Zhu; HongBo Bao; JinSheng Xiong; Peng Liang
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

Review 5.  Molecular implications of HOX genes targeting multiple signaling pathways in cancer.

Authors:  U Sangeetha Shenoy; Divya Adiga; Shama Prasada Kabekkodu; Keith D Hunter; Raghu Radhakrishnan
Journal:  Cell Biol Toxicol       Date:  2021-10-06       Impact factor: 6.691

Review 6.  Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.

Authors:  Richard Morgan; Keith Hunter; Hardev S Pandha
Journal:  Int J Cancer       Date:  2022-02-15       Impact factor: 7.316

7.  Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-β1/Smad and ERK1/2 Signaling Pathways.

Authors:  Lizhi Bai; Pan Ge; Yanni Zhang; Yi Song; Rong Xing; Dangxia Zhou
Journal:  Biomed Res Int       Date:  2022-09-16       Impact factor: 3.246

Review 8.  HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies.

Authors:  Serena Contarelli; Vita Fedele; Davide Melisi
Journal:  Cancers (Basel)       Date:  2020-11-08       Impact factor: 6.639

9.  A Systematic Review on HOX Genes as Potential Biomarkers in Colorectal Cancer: An Emerging Role of HOXB9.

Authors:  Eirini Martinou; Giulia Falgari; Izhar Bagwan; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.